Clinical Trial Update: Use of Beta-blockers and Risk of New Onset Diabetes

View source ↗

Summary

The completed trial update investigates whether use of beta-blockers is associated with an increased risk of new-onset diabetes in patients with hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Beta blockers (class) (beta-adrenergic blockers)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hypertension | Status: COMPLETED